Clinical Trials Browser

balstilimab × Tumor-Agnostic × 90 days × Clear all

NCT05572970 2026-05-06

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Neoplasms